From: The ongoing impacts of hepatitis c - a systematic narrative review of the literature
*Category (number of studies) | Country of study (number of studies) | Populations or study focus (number of studies) | Approach used (number of studies) |
---|---|---|---|
Quality of life in people with untreated hepatitis C (45) | Australia (6); Austria (2) Brazil (2); Canada (4); Egypt (1); France (1); Germany (3); Ireland (2); Italy (2); Mexico (1); Netherlands (1); Norway (2); Serbia (1); Spain (1); Sweden (1); Switzerland (1); Taiwan (1); Turkey (3); US (10) | Community and clinic populations (26); injecting drug users (2); hepatitis B and/or HIV co-infection (7); people with various stages of disease progression (4); people with comorbid conditions (3) | Quantitative approaches using surveys incorporating physical and mental health status instruments such as the SF-36 or 12, Beck Depression Inventory (45) |
Quality of life in people during or after antiviral treatment/transplant for hepatitis C (22) | Australia (1); Canada (1); Germany (1); Italy (3); Sweden (1); Taiwan (3); Turkey (2); UK(1); US (9) | During antiviral treatment (13); after antiviral treatment (5); after liver transplantation (3) | Quantitative approaches using surveys incorporating physical and mental health status instruments such as the SF-36 or 12, Beck Depression Inventory (20) |
 |  |  | Qualitative approaches involving semi-structured or in-depth interviews (2) |
Psychosocial experience of living with hepatitis C (43) | Australia (6); Canada (5); France (21); Germany (2); Ireland (1); Italy (1); Scotland (1); Turkey (1); UK (2); US (6) | Social functioning (6); life style (6); general health and well-being (9); | Quantitative approaches using surveys incorporating clinical and psychosocial data (26) |
 |  |  | Qualitative approaches involving semi-structured and/or in-depth interviews, focus groups and ethnographic observation (14) Mixed methods using semi-structured interviews and survey techniques (3) |
Experience of diagnosis and management of hepatitis C (26) | Australia (9); Australia & New Zealand (1); Canada (3); France (1); Ireland (5); Japan (1); New Zealand (1); Pakistan (1); Turkey (1); UK (3); US (15) | Diagnosis impact (6); stigma & discrimination (5); health service access (10); treatment decisions (5) | Quantitative approaches using surveys incorporating clinical and psychosocial data (11) |
 |  |  | Qualitative approaches involving semi-structured and/or in-depth interviews, focus groups or daily participant recordings (13) |
 |  |  | Mixed methods using semi-structured interviews and survey techniques (2) |